Drug Type Small molecule drug |
Synonyms IBL101 |
Target |
Mechanism PIM1 inhibitors(Proto-oncogene serine/threonine-protein kinase Pim-1 inhibitors), PIM2 inhibitors(Serine/threonine-protein kinase pim-2 inhibitors), PIM3 inhibitors(Serine/threonine-protein kinase pim-3 inhibitors) |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammatory Bowel Diseases | Preclinical | IE | - | |
Lupus Nephritis | Preclinical | IE | - | |
Psoriasis | Preclinical | IE | - | |
Rheumatoid Arthritis | Preclinical | IE | - |